788 related articles for article (PubMed ID: 33785624)
1. Cooperation between Different CRISPR-Cas Types Enables Adaptation in an RNA-Targeting System.
Hoikkala V; Ravantti J; Díez-Villaseñor C; Tiirola M; Conrad RA; McBride MJ; Moineau S; Sundberg LR
mBio; 2021 Mar; 12(2):. PubMed ID: 33785624
[TBL] [Abstract][Full Text] [Related]
2. On the Origin of Reverse Transcriptase-Using CRISPR-Cas Systems and Their Hyperdiverse, Enigmatic Spacer Repertoires.
Silas S; Makarova KS; Shmakov S; Páez-Espino D; Mohr G; Liu Y; Davison M; Roux S; Krishnamurthy SR; Fu BXH; Hansen LL; Wang D; Sullivan MB; Millard A; Clokie MR; Bhaya D; Lambowitz AM; Kyrpides NC; Koonin EV; Fire AZ
mBio; 2017 Jul; 8(4):. PubMed ID: 28698278
[TBL] [Abstract][Full Text] [Related]
3. Primed CRISPR-Cas Adaptation and Impaired Phage Adsorption in Streptococcus mutans.
Mosterd C; Moineau S
mSphere; 2021 May; 6(3):. PubMed ID: 34011685
[No Abstract] [Full Text] [Related]
4. The CRISPR Spacer Space Is Dominated by Sequences from Species-Specific Mobilomes.
Shmakov SA; Sitnik V; Makarova KS; Wolf YI; Severinov KV; Koonin EV
mBio; 2017 Sep; 8(5):. PubMed ID: 28928211
[TBL] [Abstract][Full Text] [Related]
5. Foreign DNA acquisition by the I-F CRISPR-Cas system requires all components of the interference machinery.
Vorontsova D; Datsenko KA; Medvedeva S; Bondy-Denomy J; Savitskaya EE; Pougach K; Logacheva M; Wiedenheft B; Davidson AR; Severinov K; Semenova E
Nucleic Acids Res; 2015 Dec; 43(22):10848-60. PubMed ID: 26586803
[TBL] [Abstract][Full Text] [Related]
6. Recombination between phages and CRISPR-cas loci facilitates horizontal gene transfer in staphylococci.
Varble A; Meaden S; Barrangou R; Westra ER; Marraffini LA
Nat Microbiol; 2019 Jun; 4(6):956-963. PubMed ID: 30886355
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatic evidence of widespread priming in type I and II CRISPR-Cas systems.
Nicholson TJ; Jackson SA; Croft BI; Staals RHJ; Fineran PC; Brown CM
RNA Biol; 2019 Apr; 16(4):566-576. PubMed ID: 30157725
[TBL] [Abstract][Full Text] [Related]
8. Adapting to new threats: the generation of memory by CRISPR-Cas immune systems.
Heler R; Marraffini LA; Bikard D
Mol Microbiol; 2014 Jul; 93(1):1-9. PubMed ID: 24806524
[TBL] [Abstract][Full Text] [Related]
9. Avoidance of Trinucleotide Corresponding to Consensus Protospacer Adjacent Motif Controls the Efficiency of Prespacer Selection during Primed Adaptation.
Musharova O; Vyhovskyi D; Medvedeva S; Guzina J; Zhitnyuk Y; Djordjevic M; Severinov K; Savitskaya E
mBio; 2018 Dec; 9(6):. PubMed ID: 30514784
[TBL] [Abstract][Full Text] [Related]
10. Protospacer-Adjacent Motif Specificity during Clostridioides difficile Type I-B CRISPR-Cas Interference and Adaptation.
Maikova A; Boudry P; Shiriaeva A; Vasileva A; Boutserin A; Medvedeva S; Semenova E; Severinov K; Soutourina O
mBio; 2021 Aug; 12(4):e0213621. PubMed ID: 34425703
[TBL] [Abstract][Full Text] [Related]
11. Abundant and diverse clustered regularly interspaced short palindromic repeat spacers in Clostridium difficile strains and prophages target multiple phage types within this pathogen.
Hargreaves KR; Flores CO; Lawley TD; Clokie MR
mBio; 2014 Aug; 5(5):e01045-13. PubMed ID: 25161187
[TBL] [Abstract][Full Text] [Related]
12. Long-term genomic coevolution of host-parasite interaction in the natural environment.
Laanto E; Hoikkala V; Ravantti J; Sundberg LR
Nat Commun; 2017 Jul; 8(1):111. PubMed ID: 28740072
[TBL] [Abstract][Full Text] [Related]
13. Requirements for Pseudomonas aeruginosa Type I-F CRISPR-Cas Adaptation Determined Using a Biofilm Enrichment Assay.
Heussler GE; Miller JL; Price CE; Collins AJ; O'Toole GA
J Bacteriol; 2016 Nov; 198(22):3080-3090. PubMed ID: 27573013
[TBL] [Abstract][Full Text] [Related]
14. Rarely acquired type II-A CRISPR-Cas spacers mediate anti-viral immunity through the targeting of a non-canonical PAM sequence.
Kenney CT; Marraffini LA
Nucleic Acids Res; 2023 Aug; 51(14):7438-7450. PubMed ID: 37293964
[TBL] [Abstract][Full Text] [Related]
15. Cas13-induced cellular dormancy prevents the rise of CRISPR-resistant bacteriophage.
Meeske AJ; Nakandakari-Higa S; Marraffini LA
Nature; 2019 Jun; 570(7760):241-245. PubMed ID: 31142834
[TBL] [Abstract][Full Text] [Related]
16. Impact of Different Target Sequences on Type III CRISPR-Cas Immunity.
Maniv I; Jiang W; Bikard D; Marraffini LA
J Bacteriol; 2016 Jan; 198(6):941-50. PubMed ID: 26755632
[TBL] [Abstract][Full Text] [Related]
17. A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.
Malone LM; Warring SL; Jackson SA; Warnecke C; Gardner PP; Gumy LF; Fineran PC
Nat Microbiol; 2020 Jan; 5(1):48-55. PubMed ID: 31819217
[TBL] [Abstract][Full Text] [Related]
18. Imprecise Spacer Acquisition Generates CRISPR-Cas Immune Diversity through Primed Adaptation.
Jackson SA; Birkholz N; Malone LM; Fineran PC
Cell Host Microbe; 2019 Feb; 25(2):250-260.e4. PubMed ID: 30661951
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas systems exploit viral DNA injection to establish and maintain adaptive immunity.
Modell JW; Jiang W; Marraffini LA
Nature; 2017 Apr; 544(7648):101-104. PubMed ID: 28355179
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanisms of CRISPR-Cas Immunity in Bacteria.
Nussenzweig PM; Marraffini LA
Annu Rev Genet; 2020 Nov; 54():93-120. PubMed ID: 32857635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
